Matrix Metalloproteinase-14 Expression and Its Prognostic Value in Cervical Carcinoma

Cell Biochemistry and Biophysics

Volumn 70, Issue 2, 2014, Pages 729-734

  Wang, Huayi ^a   Zhang, Xianhua ^b   Huang, Liming ^c   Li, Jia ^a   Qu, Shuyun ^b   Pan, Fenglian ^b  

^a Department of Infectious Diseases   (China)

^b First People's Hospital of Jingzhou   (China)

^c ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Cervical carcinoma; MMP 14; Prognosis; Survival

Indexed keywords

MATRIX METALLOPROTEINASE 14; MMP14 PROTEIN, HUMAN;

ADULT; FEMALE; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; PROGNOSIS; SURVIVAL; UTERINE CERVICAL NEOPLASMS;

ADULT; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 14; PROGNOSIS; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 84924073365     PISSN: 10859195     EISSN: 15590283     Source Type: Journal    
DOI: 10.1007/s12013-014-9974-8     Document Type: Article

References (25)

1. Devy, L., Huang, L., Naa, L., Yanamandra, N., Pieters, H., et al. (2009). Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis. Cancer Research,69, 1517–1526.
2. Kim, G. E., Kim, J. H., Lee, K. H., Choi, Y. D., Lee, J. S., et al. (2012). Stromal matrix metalloproteinase-14 expression correlates with the grade and biological behavior of mammary phyllodes tumors. Applied Immunohistochemistry & Molecular Morphology,20, 298–303.
3. Zhang, H., Qi, M., Li, S., Qi, T., Mei, H., et al. (2012). microRNA-9 targets matrix metalloproteinase 14 to inhibit invasion, metastasis, and angiogenesis of neuroblastoma cells. Molecular Cancer Therapeutics,11, 1454–1466.
4. Watanabe, H. (2010). Extracellular matrix–regulation of cancer invasion and metastasis. Gan To Kagaku Ryoho,37, 2058–2061.
5. Tee, Y. T., Han, C. P., Ko, J. L., Chen, G. D., Yang, S. F., et al. (2007). Evaluation of matrix metalloproteinase 2 expression in cervical carcinogenesis using tissue array and integrated optical density for immunoreactivity. Reproductive Sciences,14, 719–726.
6. Zarrabi, K., Dufour, A., Li, J., Kuscu, C., Pulkoski-Gross, A., et al. (2011). Inhibition of matrix metalloproteinase 14 (MMP-14) -mediated cancer cell migration. Journal of Biological Chemistry,286, 33167–33177.
7. Chen, T. Y., Li, Y. C., Liu, Y. F., Tsai, C. M., Hsieh, Y. H., et al. (2011). Role of MMP14 gene polymorphisms in susceptibility and pathological development to hepatocellular carcinoma. Annals of Surgical Oncology,18, 2348–2356.
8. Dong, Q., Yu, D., Yang, C. M., Jiang, B., & Zhang, H. (2010). Expression of the reversion-inducing cysteine-rich protein with Kazal motifs and matrix metalloproteinase-14 in neuroblastoma and the role in tumour metastasis. International Journal of Experimental Pathology,91, 368–373.
9. Laudański, P., Swiatecka, J., Kozłowski, L., Leśniewska, M., Wojtukiewicz, M., et al. (2010). Increased serum level of membrane type 1-matrix metalloproteinase (MT1-MMP/MMP-14) in patients with breast cancer. Folia Histochemica et Cytobiologica,48, 101–103.
10. Littlepage, L. E., Sternlicht, M. D., Rougier, N., Phillips, J., Gallo, E., et al. (2010). Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression. Cancer Research,70, 2224–2234.
11. Fidler, I. J. (2000). Angiogenesis and cancer metastasis. Cancer Journal,2, S134–S141.
12. Cork, S. M., Kaur, B., Devi, N. S., Cooper, L., Saltz, J., et al. (2012). A proprotein convertase/MMP-14 proteolytic cascade releases a novel 40 kDa vasculostatin from tumor suppressor BAI1. Oncogene,31(50), 5144–5152.
13. Aplin, A. C., Zhu, W. H., Fogel, E., & Nicosia, R. F. (2009). Vascular regression and survival are differentially regulated by MT1-MMP and TIMPs in the aortic ring model of angiogenesis. American Journal of Physiology. Cell Physiology,297, C471–C480.
14. Devy, L., Huang, L., Naa, L., Yanamandra, N., Pieters, H., et al. (2009). Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis. Cancer Research,69, 1517–1526.
15. Roebuck, M. M., Helliwell, T. R., Chaudhry, I. H., Kalogrianitis, S., Carter, S., et al. (2005). Matrix metalloproteinase expression is related to angiogenesis and histologic grade in spindle cell soft tissue neoplasms of the extremities. American Journal of Clinical Pathology,123, 405–414.
16. Ricke, W. A., Smith, G. W., Reynolds, L. P., Redmer, D. A., & Smith, M. F. (2002). Matrix metalloproteinase (2, 9, and 14) expression, localization, and activity in ovine corpora lutea throughout the estrous cycle. Biology of Reproduction,66, 1083–1094.
17. Niewiarowska, J., Brézillon, S., Sacewicz-Hofman, I., Bednarek, R., Maquart, F. X., et al. (2011). Lumican inhibits angiogenesis by interfering with α2β1 receptor activity and downregulating MMP-14 expression. Thrombosis Research,128, 452–457.
18. Heikkilä, P., Teronen, O., Hirn, M. Y., Sorsa, T., Tervahartiala, T., et al. (2003). Inhibition of matrix metalloproteinase-14 in osteosarcoma cells by clodronate. Journal of Surgical Research,111, 45–52.
19. Naglich, J. G., Jure-Kunkel, M., Gupta, E., Fargnoli, J., Henderson, A. J., et al. (2001). Inhibition of angiogenesis and metastasis in two murine models by the matrix metalloproteinase inhibitor, BMS-275291. Cancer Research,61, 8480–8485.
20. Zhai, Y., Hotary, K. B., Nan, B., Bosch, F. X., Muñoz, N., et al. (2005). Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion. Cancer Research,65, 6543–6550.
21. Shields, M. A., Dangi-Garimella, S., Redig, A. J., & Munshi, H. G. (2012). Biochemical role of the collagen-rich tumour microenvironment in pancreatic cancer progression. Biochemical Journal,441, 541–552.
22. Poincloux, R., Lizárraga, F., & Chavrier, P. (2009). Matrix invasion by tumour cells: A focus on MT1-MMP trafficking to invadopodia. Journal of Cell Science,122, 3015–3024.
23. Wolf, K., Wu, Y. I., Liu, Y., Geiger, J., Tam, E., et al. (2007). Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nature Cell Biology,9, 893–904.
24. von Lampe, B., Barthel, B., Coupland, S. E., Riecken, E. O., & Rosewicz, S. (2000). Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut,47, 63–73.
25. Kim, J. H., Kim, T. H., Jang, J. W., Jang, Y. J., Lee, K. H., et al. (2001). Analysis of matrix metalloproteinase mRNAs expressed in hepatocellular carcinoma cell lines. Molecules and Cells,12, 32–40.